The DOI matches its Crossref record; 144 of the 146 references it cites were found in a registry or an index.
HLA-DR15 Haplotype and Multiple Sclerosis: A HuGE Review
Abstract
An association between multiple sclerosis (MS) and the human leukocyte antigen (HLA) complex, a dense cluster of genes on the short arm of chromosome 6, was first noted over 30 years ago. In Caucasian populations of Northern European descent, the DR15 haplotype (DRB1*1501-DQA1*0102-DQB1*0602) has been hypothesized to be the primary HLA genetic susceptibility factor for MS. However, studies of other populations have produced varying results. Thus, the authors reviewed the literature for articles on the association between the DR15 haplotype and MS. They identified 72 papers meeting the inclusion criteria: human genetic studies written in English that were published between 1993 and 2004 and that reported allele frequencies for HLA-DRB1*1501, HLA-DQA1*0102, or HLA-DQB1*0602 or the frequency of the DRB1*1501-DQA1*0102-DQB1*0602 haplotype. Most of the studies identified used a case-control design (n = 60), while the remainder used a family-based design (n = 22). In most of these papers, investigators reported a higher frequency of the DR15 haplotype and/or its component alleles among MS cases than among controls. However, the authors' confidence in these results is tempered by factors related to study design that may have biased the outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the DR15 haplotype and its component alleles also associate with protection against diabetes108, a high risk for multiple sclerosis109,110, and risk or protective effects with many other immune-mediated diseases”
From Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) · cites this paper as [110]
In the citing paper
“Beyond these findings, a specific class II human leukocyte antigen (HLA)-DR haplotype, DR15, has been suggested to impart risk for both AD and MS (7, 8).”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [7]
Citations
Cites
Haines, J. L., Ter‐Minassian, M., Bazyk, A., Gusella, J. F., Kim, D. J., Terwedow, H. A., Pericak‐Vance, M. A., Rimmler, J. B., Haynes, C. S., Roses, A. D., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-469 · Cited by 650
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
Lang, H., Jacobsen, H. J., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L. S., Hjorth, P., Søndergaard, L., Svejgaard, A., Wucherpfennig, K. W., et al. (2002) · Nature Immunology · doi:10.1038/ni835 · Cited by 592
Epstein-Barr virus and multiple sclerosis
Robinson, W. H., & Steinman, L. (2022) · Science · doi:10.1126/science.abm7930 · Cited by 338
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B., Baranzini, S. E., Bugawan, T. L., Khan, O. A., Lincoln, R., Swerdlin, A., Mignot, E. J.-M., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 334
Multiple Sclerosis: Association with HL—A3
NAITO, S., NAMEROW, N., MICKEY, M. R., & TERASAKI, P. I. (1972) · Tissue Antigens · doi:10.1111/j.1399-0039.1972.tb00111.x · Cited by 308
Yamasaki, K., Kira, J., Kawano, Y., Kobayashi, T., Kanai, T., Nishimura, Y., Matsushita, S., Hasuo, K., & Tobimatsu, S. (1996) · Annals of Neurology · doi:10.1002/ana.410400405 · Cited by 301
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J. A., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Haines, J. L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 281
Vitamin D and Multiple Sclerosis
Hayes, C. E., Cantorna, M. T., & DeLuca, H. F. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44153a · Cited by 236
van der Mei, I. A. F., Ponsonby, A., Blizzard, L., & Dwyer, T. (2001) · Neuroepidemiology · doi:10.1159/000054783 · Cited by 216
Multiple sclerosis in the Faroe Islands
Kurtzke, J. F., & Heltberg, A. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00268-7 · Cited by 206
Epstein-Barr Virus and Multiple Sclerosis
Ascherio, A., & Munch, M. (2000) · Epidemiology · doi:10.1097/00001648-200003000-00023 · Cited by 206
Yamasaki, K. (1999) · Brain · doi:10.1093/brain/122.9.1689 · Cited by 180
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
Hensiek, A. E. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.184 · Cited by 167
Freedman, D. M., Dosemeci, M., & Alavanja, M. C. R. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.6.418 · Cited by 166
CTLA4 promoter and exon 1 dimorphisms in multiple sclerosiso
Harbo, H. F., Celius, E. G., Vartdal, F., & Spurkland, A. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530112.x · Cited by 160
Genetic basis for clinical expression in multiple sclerosis
The Multiple Sclerosis Genetics Group, Barcellos, L. F., Oksenberg, J. R., Green, A. J., Bucher, P., Rimmler, J. B., Schmidt, S., Garcia, M., Lincoln, R., Pericak‐Vance, M. A., et al. (2002) · Brain · doi:10.1093/brain/awf009 · Cited by 154
Marrosu, M. G. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 154
Major histocompatibility complex class II alleles and the course and outcome of MS
Weinshenker, B. G., Santrach, P. J., Bissonet, A. S., McDonnell, S. K., Schaid, D. J., Moore, S. B., & Rodríguez, M. T. (1998) · Neurology · doi:10.1212/wnl.51.3.742 · Cited by 152
Harbo, H. F., Lie, B. A., Sawcer, S. J., Celius, E. G., Dai, K., Oturai, A. B., Hillert, J. A., Lorentzen, Å. R., Laaksonen, M., Myhr, K. M., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00173.x · Cited by 149
The incidence and prevalence of reported multiple sclerosis
Baum, H. M., & Rothschild, B. B. (1981) · Annals of Neurology · doi:10.1002/ana.410100504 · Cited by 144
DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population
Marrosu, M. G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1235 · Cited by 137
Genetic predisposition to multiple sclerosis as revealed by immunoprinting
Epplen, C., Jäckel, S., dos Santos, E. J. M., D’Souza, M., Poehlau, D., Dotzauer, B., Sindern, E., Haupts, M. R., Rüde, K., Weber, F., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410309 · Cited by 135
Hillert, J. A., & Olerup, O. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.163 · Cited by 133
Marrosu, M. G., Murru, M. R., Costa, G., Cucca, F., Sotgiu, S., Rosati, G., & Francesco Muntoni, A. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64074-9 · Cited by 132
Fogdell‐Hahn, A., Hillert, J. A., Sachs, C., & Olerup, O. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb02503.x · Cited by 124
HLA-DQ Locus of the Human Leukocyte Antigen Complex and Type 1 Diabetes Mellitus: A HuGE Review
Dorman, J. S., & Bunker, C. H. (2000) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a018034 · Cited by 122
Allen, M., Sandberg‐Wollheim, M., Sjögren, K., Erlich, H. A., Pettersson, U., & Gyllensten, U. B. (1994) · Human Immunology · doi:10.1016/0198-8859(94)90099-x · Cited by 114
Herpesvirus and multiple sclerosis.
Simmons, A. (2001) · PubMed · Cited by 103
Does Immunosuppressive Ultraviolet Radiation Explain the Latitude Gradient for Multiple Sclerosis?
McMichael, A. J., & Hall, A. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00005 · Cited by 102
Mycko, M. P., Kwinkowski, M., Tronczyńska, E., Szymańska, B., & Selmaj, K. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440113 · Cited by 97
Beall, S. S., Biddison, W. E., McFarlin, D. E., McFarland, H. F., & Hood, L. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90163-s · Cited by 94
Rubio, J. P., Bahlo, M., Butzkueven, H., van der Mei, I. A. F., Sale, M. M., Dickinson, J. L., Groom, P., Johnson, L., Simmons, R. D., Tait, B. D., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339932 · Cited by 94
HLA-DR and -DQ Associations with Multiple Sclerosis in Turkey
Saruhan‐Direskeneli, G., Esin, S., Baykan, B. B., Örnek, I., Vaughan, R., & Eraksoy, M. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00086-4 · Cited by 94
HL-A Antigen Frequencies in Multiple Sclerosis
Bertrams, J., & Kuwert, E. K. (2008) · European Neurology · doi:10.1159/000114414 · Cited by 90
High-resolution DNA melting curve analysis to establish HLA genotypic identity.
Zhou, L., van der Steen, J., Wang, L., Fuller, T., Taylor, M., Palais, B., & Wittwer, C. T. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00248.x · Cited by 86
Casetta, I., Granieri, E., Malagù, S., Tola, M. R., Paolino, E., Caniatti, L. M., Govoni, V., Monetti, V. C., & Fainardi, E. (1994) · Neuroepidemiology · doi:10.1159/000110369 · Cited by 84
HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews
Kwon, O. J., Karni, A., Israel, S., Brautbar, C., Amar, A., Meiner, Z., Abramsky, O., & Karussis, D. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.555 · Cited by 82
DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro‐Brazilians
Caballero, A., Alves‐Leon, S. V., Papais‐Alvarenga, R., Fernández, Ó., Navarro, G., & Alonso, A. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540511.x · Cited by 78
de la Concha, E. G., Arroyo, R., Crusius, J. B. A., Campillo, J. A., Martín, C. E. S., de Seijas, E. V., Peña, A. S., Clavería, L. E., & Fernández‐Arquero, M. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00153-7 · Cited by 77
The genetic epidemiology of multiple sclerosis
Kenealy, S. J., Pericak‐Vance, M. A., & Haines, J. L. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.08.005 · Cited by 77
Evidence of Linkage with HLA-DR in DRB1*15-Negative Families with Multiple Sclerosis
Ligers, A., Dyment, D. A., Willer, C. J., Sadovnick, A. D., Ebers, G. C., RISCH, N. J., & Hillert, J. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323480 · Cited by 76
HLA class II associated risk and protection against multiple sclerosis—a Finnish family study
Laaksonen, M., Pastinen, T., Sjöroos, M., Kuokkanen, S., Ruutiainen, J., Sumelahti, M., Reijonen, H., Salonen, R., Wikstrom, J., Panelius, M., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00456-8 · Cited by 75
Villoslada, P., Barcellos, L. F., Río, J., Begovich, A. B., Tintoré, M., Sastre‐Garriga, J., Baranzini, S. E., Casquero, P., Hauser, S. L., Montalbán, X., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00215-1 · Cited by 75
Ballerini, C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.015 · Cited by 74
Multiple sclerosis and the HLA-D region: linkage and association studies
Kellar-Wood, H., Wood, N. W., Holmans, P., Clayton, D. G., Robertson, N. P., & Compston, D. A. S. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00015-t · Cited by 73
McDonnell, G. V., Mawhinney, H., Graham, C. A., Hawkins, S. A., & Middleton, D. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00084-2 · Cited by 72
HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands
Kikuchi, S., Fukazawa, T., Niino, M., Yabe, I., Miyagishi, R., Hamada, T., Hashimoto, S. A., & Tashiro, K. (2003) · Neurology · doi:10.1212/01.wnl.0000048202.09147.9e · Cited by 72
Genetic Epidemiology of Multiple Sclerosis
Sadovnick, A. D., Dyment, D. A., & Ebers, G. C. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017951 · Cited by 71
Fukazawa, T., Yamasaki, K., Ito, H., Kikuchi, S., Minohara, M., Horiuchi, I., Tsukishima, E., Sasaki, H., Hamada, T., Nishimura, Y., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550302.x · Cited by 71
Susceptibility to multiple sclerosis: interplay between genes and environment
Willer, C. J., & Ebers, G. C. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200006000-00002 · Cited by 70
HLA associations with multiple sclerosis in the Canary Islands
Coraddu, F., Reyes-Yanez, M. P., Parra, A. G. M., Gray, J., Smith, S. I., Taylor, C. J., & Compston, D. A. S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00074-5 · Cited by 69
HLA-DRB1 and disease outcome in multiple sclerosis
Weatherby, S. J. M., Thomson, W., Pepper, L., Donn, R. P., Worthington, J., Mann, C. L. A., Davies, M. B., Fryer, A. A., Boggild, M., Young, C. A., et al. (2001) · Journal of Neurology · doi:10.1007/s004150170205 · Cited by 68
Hillert, J. A., Leng, C., & Olerup, O. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90006-s · Cited by 67
Lampis, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.2959 · Cited by 67
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
de Jong, B. A., Huizinga, T. W. J., Zanelli, E. H., Giphart, M. J., Bollen, E. L. E. M., Uitdehaag, B. M. J., Polman, C. H., & Westendorp, R. G. J. (2002) · Neurology · doi:10.1212/wnl.59.4.549 · Cited by 61
HLA and prognosis in multiple sclerosis
Runmarker, B., Martinsson, T., Wahlström, J., & Andersen, O. (1994) · Journal of Neurology · doi:10.1007/bf02033356 · Cited by 61
Association and linkage of juvenile MS with HLA-DR2(15) in Russians
Бойко, А. Н., Gusev, E. I., Sudomoina, M. A., Alekseenkov, A. D., Кулакова, О. Г., Bikova, O. V., Маслова, О. И., Гусева, М. Р., Boiko, S., Guseva, M. E., et al. (2002) · Neurology · doi:10.1212/wnl.58.4.658 · Cited by 60
HLA typing in the United Kingdom multiple sclerosis genome screen
Coraddu, F., Sawcer, S. J., Feakes, R. W., Chataway, J., Broadley, S., Jones, H. B., Clayton, D. G., Gray, J., Smith, S. I., Taylor, C. J., et al. (1998) · Neurogenetics · doi:10.1007/s100480050048 · Cited by 59
Allcock, R. J. N., de la Concha, E. G., Fernández‐Arquero, M., Vigil, P., Conejero, L., Arroyo, R., & Price, P. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00127-5 · Cited by 58
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain
Fern�ndez, O., Fern�ndez, V., Alonso, A., Caballero, A., Luque, G., Bravo, M. J., Le�n, A., Mayorga, C., Leyva, L., & de Ram�n, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0350-2 · Cited by 57
The HLA locus and multiple sclerosis in Sicily
Brassat, D., Salemi, G., Barcellos, L. F., McNeill, G., Proia, P., Hauser, S. L., Oksenberg, J. R., & Savettieri, G. (2005) · Neurology · doi:10.1212/01.wnl.0000149765.71212.0a · Cited by 55
HLA‐DP‐associated susceptibility to the optico‐spinal form of multiple sclerosis in the Japanese
Ito, H., Yamasaki, K., Kawano, Y., Horiuchi, I., Yun, C.-H., Nishimura, Y., & Kira, J. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb02282.x · Cited by 54
Amirzargar, A., Mytilineos, J., Yousefipour, A., Farjadian, S., Scherer, S., Opelz, G., & Ghaderi, A. A. (1998) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.1998.00101.x · Cited by 53
HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis
la Barrera, C. A., Zúñiga, J., Ruiz‐Morales, J., Estañol, B., Granados, J., & Llorente, L. (2000) · Neurology · doi:10.1212/wnl.55.12.1897 · Cited by 51
Multiple sclerosis and exposure to solvents, ionizing radiation and animals.
Landtblom, A., Flodin, U., Karlsson, M., Pålhagen, S., Axelson, O., & Söderfeldt, B. A. (1993) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.1455 · Cited by 51
HLA‐DR, ‐DQA1 and ‐DQB1 associations in Australian multiple sclerosis patients
Stewart, G. J., Teutsch, S. M., Castle, M., Heard, R. N., & Bennetts, B. (1997) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.1997.00252.x · Cited by 50
Multiple Sclerosis, Solvents, and Pets
Flodin, U. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520300038015 · Cited by 49
Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis
Nejentsev, S., Laaksonen, M., Tienari, P. J., Fernández, Ó., Cordell, H. J., Ruutiainen, J., Wikstrom, J., Pastinen, T., Kuokkanen, S., Hillert, J. A., et al. (2003) · Human Immunology · doi:10.1016/s0198-8859(02)00825-x · Cited by 49
The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families
Hillert, J. A., Käll, T.-B., Vrethem, M., Fredrikson, S., Ohlson, M., & Olerup, O. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90219-4 · Cited by 49
Reappraisal of HLA in Multiple Sclerosis: Close Linkage in Multiplex Families
Tienari, P. J., Wikstrom, J., Koskimies, S., Partanen, J., Palo, J., & Peltonen, L. (1993) · European Journal of Human Genetics · doi:10.1159/000472423 · Cited by 49
Dyment, D. A., Steckley, J. L., Willer, C. J., Armstrong, H., Sadovnick, A. D., RISCH, N. J., & Ebers, G. C. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00493-3 · Cited by 48
D’Alfonso, S., Nisticò, L., Zavattari, P., Marrosu, M. G., Murru, R., Lai, M., Massacesi, L., Ballerini, C., Gestri, D., Salvetti, M., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200301 · Cited by 47
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS
Hauser, S. L., Oksenberg, J. R., Lincoln, R., Garovoy, J., Beck, R. W., Cole, S. R., Moke, P. S., Kip, K. E., Gal, R. L., Long, D. T., et al. (2000) · Neurology · doi:10.1212/wnl.54.9.1859 · Cited by 47
Chromosome 19 Single-Locus and Multilocus Haplotype Associations With Multiple Sclerosis
Barcellos, L. F. (1997) · JAMA · doi:10.1001/jama.1997.03550150060036 · Cited by 47
Ono, T., Zambenedetti, M. R., Yamasaki, K., Kawano, Y., Kamikawaji, N., Ito, H., Sakurai, M., Nishimura, Y., Kira, J., Kanazawa, I., et al. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03084.x · Cited by 46
Hockertz, M. K., Paty, D. W., & Beall, S. S. (1998) · The American Journal of Human Genetics · doi:10.1086/301700 · Cited by 44
Multiple sclerosis in Arabs in Jordan
Al-Din, A. S. N., Elkhateeb, M., Kurdi, A., Mubaidin, A., Wriekat, A., Al-Shehab, A., & Khalil, R. W. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00092-g · Cited by 44
Zivadinov, R., Uxa, L., Zacchi, T., Nasuelli, D., Ukmar, M., Furlan, C., Mucelli, R. P., Tommasi, M. A., Locatelli, L., Ulivi, S., et al. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0164-7 · Cited by 44
Ohashi, T., Yamamura, T., Inobe, J.-I., Kondo, T., Kunishita, T., & Tabira, T. (1995) · International Immunology · doi:10.1093/intimm/7.11.1771 · Cited by 43
Genetic interaction of CTLA‐4 with HLA‐DR15 in multiple sclerosis patients
Alizadeh, M., Babron, M., Birebent, B., Matsuda, F., Quelvennec, E., Liblau, R., Cournu‐Rebeix, I., Momigliano‐Richiardi, P., Sequeiros, J., Yaouanq, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10617 · Cited by 42
HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis
J., J., Nishimura, M., Mine, H., Saji, H., Ohta, M., Saida, K., Ozawa, K., Kawakami, H., Saida, T., & Uchiyama, T. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00189-1 · Cited by 42
Kelly, M. A., Cavan, D. A., Penny, M. A., Mijovic, C. H., Jenkins, D. J. A., Morrissey, S., Miller, D. H., Barnett, A. H., & Francis, D. A. (1993) · Human Immunology · doi:10.1016/0198-8859(93)90184-3 · Cited by 42
Rasmussen, H. B., Kelly, M. A., Francis, D. A., & Clausen, J. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00502-5 · Cited by 40
Oh, H. H., Kwon, S. H., Kim, C. W., Choe, B., Ko, C. W., Cha, H. J., Suh, J. S., & Lee, J. H. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.3.426 · Cited by 39
Quelvennec, E., Béra, O., Cabre, P., Alizadeh, M., Smadja, D., Jugdé, F., Edan, G., & Sémana, G. (2003) · Tissue Antigens · doi:10.1046/j.0001-2815.2002.00008.x · Cited by 38
Modes of Action of HLA-DR Susceptibility Specificities in Multiple Sclerosis
Modin, H., Olsson, W., Hillert, J. A., & Masterman, T. (2004) · The American Journal of Human Genetics · doi:10.1086/420977 · Cited by 38
Spurkland, A., Celius, E. G., Knutsen, I., Belske, A., Thorsby, E., & Vartdal, F. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02828.x · Cited by 37
The T-cell receptor beta locus and susceptibility to multiple sclerosis
Wood, N. W., sawcer, S. J., Kellar-Wood, H., Holmans, P., Clayton, D. G., Robertson, N. P., & Compston, D. A. S. (1995) · Neurology · doi:10.1212/wnl.45.10.1859 · Cited by 37
Evidence for Linkage Disequilibrium Between HLA-DRB1 Gene and Multiple Sclerosis
Yaouanq, J., Sémana, G., Eichenbaum, S., Quelvennec, E., Roth, M., Clanet, M., Edan, G., & Clerget‐Darpoux, F. (1997) · Science · doi:10.1126/science.276.5313.661g · Cited by 36
Kankonkar, S., Jeyanti, G., Singhal, B. S., & Shankarkumar, U. (2003) · Human Immunology · doi:10.1016/s0198-8859(03)00014-4 · Cited by 36
Linkage analysis of HLA class II Genes in Swedish multiplex families with multiple sclerosis
Fogdell‐Hahn, A., Olerup, O., Fredrikson, S., Vrethem, M., & Hillert, J. A. (1997) · Neurology · doi:10.1212/wnl.48.3.758 · Cited by 35
Boon, M., Nolte, I. M., Bruinenberg, M., Spijker, G. T., Terpstra, P., Raelson, J., Keyser, J. D., Zwanikken, C., Hulsbeek, M. M. F., Hofstra, R. M. W., et al. (2001) · Neurogenetics · doi:10.1007/s100480100121 · Cited by 35
Ghabanbasani, M. Z., Gu, X. X., Spaepen, M., Vandevyver, C. D. B., Raus, J., Marynen, P., Carton, H., & Cassiman, J. J. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00027-y · Cited by 34
Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele
Fukazawa, T., Kikuchi, S., Sasaki, H., Yabe, I., Miyagishi, R., Hamada, T., & Tashiro, K. (2000) · Journal of Neurology · doi:10.1007/s004150050558 · Cited by 32
Al-Din, A. S. N., Kurdi, A., Mubaidin, A. F., El-Khateeb, M., Khalil, R. W., & Wriekat, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00276-8 · Cited by 32
HLA‐DQA1 and ‐DQB1 associations with multiple sclerosis in Sardinia and French Canada
Haegert, D. G., Francesco Muntoni, A., Murru, M. R., Costa, G., Francis, G. S., & Marrosu, M. G. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.548 · Cited by 31
Haegert, D. G., Swift, F. V., & Benedikz, J. E. G. (1996) · Neurology · doi:10.1212/wnl.46.4.1107 · Cited by 31
Kelly, M. A., Jacobs, K. H., Penny, M. A., Mijovic, C. H., Nightingale, S., Barnett, A. H., & Francis, D. A. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb02439.x · Cited by 31
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis
Cournu‐Rebeix, I., Génin, E., Lesca, G., Azoulay-Cayla, A., Tubridy, N. J., Noé, E., Clanet, M., Edan, G., Clerget‐Darpoux, F., Sémana, G., et al. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6364009 · Cited by 30
Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran
Kalanie, H., Kamgooyan, M., Sadeghian, H., & Kalanie, A. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600504 · Cited by 28
Vandevyver, C. D. B., Buyse, I. M., Philippaerts, L., Ghabanbasani, Z., Medaer, R., Carton, H., Cassiman, J. J., & Raus, J. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90158-9 · Cited by 27
Dekker, J., Eastsal, S., Jakobson, I., Gao, X., Strwart, G. J., Buhler, M. M., Hawkins, B. R., Higgins, D. A., Yu, Y. L., & Serjeantson, S. W. (1993) · Tissue Antigens · doi:10.1111/j.1399-0039.1993.tb01974.x · Cited by 27
Nelson, N., Robins, T. G., White, R. F., & Garrison, R. P. (1994) · Occupational and Environmental Medicine · doi:10.1136/oem.51.5.302 · Cited by 26
Organic solvents and multiple sclerosis: a case-control study
Grønning, M., Albrektsen, G., Kvåle, G., Moen, B. E., Aarli, J. A., & Nyland, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04229.x · Cited by 26
Clinical infections and multiple sclerosis: contribution from analytical epidemiology.
Casetta, I., & Granieri, E. (2000) · PubMed · Cited by 26
Zipp, F., Windemuth, C., Pankow, H., DICHGANS, J., Wienker, T. F., Martinꝉ, R., & Müller, C. A. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00173-7 · Cited by 25
Kelly, M. A., Zhang, Y., Penny, M. A., Jacobs, K. H., Cavan, D. A., Mijovic, C. H., Chou, K., Barnett, A. H., & Francis, D. A. (1995) · Human Immunology · doi:10.1016/0198-8859(94)00094-7 · Cited by 25
Shao, W., Tang, J., Dorak, M. T., Song, W., Lobashevsky, E. S., Cobbs, C., Wrensch, M., & Kaslow, R. A. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00295.x · Cited by 25
HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients
Bennetts, B., Teutsch, S. M., Buhler, M. M., Heard, R. N., & Stewart, G. J. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00054-3 · Cited by 25
Haegert, D. G., & Francis, G. S. (1993) · Neurology · doi:10.1212/wnl.43.6.1207 · Cited by 24
The combination of HLA-DR1 and HLA-DR53 protects against MS
Luomala, M., Elovaara, I., Ukkonen, M., Koivula, T., & Lehtimäki, T. J. (2001) · Neurology · doi:10.1212/wnl.56.3.383 · Cited by 24
Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis
Rasmussen, H. B., Kelly, M. A., & Clausen, J. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700203 · Cited by 23
Role of Predisposing and Protective HLA-DQA and HLA-DQB Alleles in Sardinian Multiple Sclerosis
Marrosu, M. G., Francesco Muntoni, A., Murru, M. R., Costa, G., Congia, M., Marrosu, M. G., Aiello, I., Pirastu, M., & Cianchetti, C. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540030022008 · Cited by 23
Obstacles to identifying viruses that cause autoimmune disease
von Herrath, M. G. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00227-7 · Cited by 23
Multiple sclerosis in the tropics: genetic association to STR’s loci spanning the HLA and TNF
Palacio, L. G., Rivera, D., Builes, J. J., Jiménez, M. E., Salgar, M., Anaya, J., Jiménez, I., Camargo, M., Arcos‐Burgos, M., & Sánchez, J. L. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms804oa · Cited by 23
The HLA-DR13 haplotype is associated with “benign” multiple sclerosis in northeast Italy
Perini, P., Tagliaferri, C., Belloni, M., Biasi, G., & Gallo, P. (2001) · Neurology · doi:10.1212/wnl.57.1.158 · Cited by 23
HLA Typing in Acute Optic Neuritis
Frederiksen, J. L. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550130058016 · Cited by 22
Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians
Guerini, F. R., Ferrante, P., Losciale, L., Caputo, D., Lombardi, M. L., Pirozzi, G., Luongo, V., Sudomoina, M. A., Andreewski, T. V., Alekseenkov, A. D., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000079372.54703.a8 · Cited by 21
Pina, M. A., Ara, J. R., Lasierra, P., Modrego, P. J., & Larrad, L. (1999) · Neuroepidemiology · doi:10.1159/000026212 · Cited by 21
The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus.
HAAHR, S., & Munch, M. (2000) · PubMed · Cited by 21
Eoli, M., Pandolfo, M., Amoroso, A., Salmaggi, A., Zaffaroni, M., Gasparini, P., DiDonato, S., Milanese, C., & Zeviani, M. (1995) · European Journal of Human Genetics · doi:10.1159/000472314 · Cited by 20
DR2/DQwl Inheritance and haplotype sharing in affected siblings from multiple sclergis families
Voskuhl, R. R., Goldstein, A. M., Voskuhl, T., Davey, R. J., & McFarland, H. F. (1996) · Annals of Neurology · doi:10.1002/ana.410390618 · Cited by 20
ANALYSIS OF HLA‐CLASS II DQA1, DQB1, DRB1 and DPB1 IN ITALIAN MULTIPLE SCLEROSIS PATIENTS
Ciusani, E., Allen, M., Sandberg‐Wollheim, M., Eoli, M., Salmaggi, A., Milanese, C., Nespolo, A., & Gyllensten, U. (1995) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1995.tb00227.x · Cited by 20
Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children.
Boiko, A. N., Me, G., Mr, G., Sy, B., Sudomoina, M. A., Bikova, O. V., Maslova, O. I., Favorova, O. O., & Gusev, E. I. (2000) · PubMed · Cited by 20
The DRB1 Val86/Val86genotype associates with multiple sclerosis in Australian patients
Teutsch, S. M., Bennetts, B., Buhler, M. M., Heard, R. N., & Stewart, G. J. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00033-6 · Cited by 19
Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity
Hillert, J. A., Käll, T.-B., Olerup, O., & Söderström, M. B. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb07047.x · Cited by 17
Karni, A., Kohn, Y., Saftirmnn, C., Abraimsky, O., Barcellos, L. F., Oksenberg, J. R., Kahana, E., Karussis, D., Chapman, J., & Brautbur, C. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500i607 · Cited by 17
Multiple Sclerosis: Association to HLA DQα in a Tropical Population
Arcos‐Burgos, M., Palacio, G., Sánchez, J. L., Londoño, A. C., Uribe, C. S., Jiménez, M. E., Villa, A., Anaya, J., Bravo, M. L. J., Jaramillo, N., et al. (1999) · Experimental and Clinical Immunogenetics · doi:10.1159/000019105 · Cited by 14
Multiple sclerosis in the Faroe Islands VI. Studies of HLA markers
Jersild, C., Kurtzke, J. F., Riisom, K., Heltberg, A., Arbuckle, J. D., & Hyllested, K. (1993) · Tissue Antigens · doi:10.1111/j.1399-0039.1993.tb02245.x · Cited by 14
Ristori, G., Carcassi, C., Lai, S., Fiori, P., Cacciani, A., Floris, L. A., Montesperelli, C., Giovanni, S. D., Buttinelli, C., Contu, L., et al. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00069-6 · Cited by 13
Montanaro, D., Sanna, V., Matarese, G., Larby, B. B., Racioppi, L., Carrieri, P. B., Bruno, R., Davey, N. J., Zappacosta, S., & Fontana, S. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01457.x · Cited by 13
Multiple Sclerosis, Solvents, and Pets
Gard, Z., & Heuser, G. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530020022009 · Cited by 13
Karni, A., Kohn, Y., Safirman, C., Abramsky, O., Barcellos, L., Oksenberg, J. R., Kahana, E., Karussis, D., Chapman, J., & Brautbar, C. (1999) · Multiple Sclerosis Journal · doi:10.1191/135245899678846438 · Cited by 12
Involvement ofBRCA1 andBRCA2 in breast cancer in a western Finnish sub-population
P��kk�nen, K., Sauramo, S., Sarantaus, L., Vahteristo, P., Hartikainen, A., Vehmanen, P., Ignatius, J., Ollikainen, V., K��ri�inen, H., Vauramo, E., et al. (2001) · Genetic Epidemiology · doi:10.1002/1098-2272(200102)20:2 · Cited by 11
T cell receptor β chain genotyping in Australian relapsing-remitting multiple sclerosis patients
Buhler, M. M., Bennetts, B., Heard, R. N., & Stewart, G. J. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600302 · Cited by 11
Uría, D. F., Gutierrez, V., Menes, B. B., Arribas, J. M., & López‐Larrea, C. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.6.722 · Cited by 11
Alpérovitch, A., Berr, C., Cambon‐Thomsen, A., Puel, J., Dugoujon, J., Ruidavets, J., & Clanet, M. (1991) · Human Immunology · doi:10.1016/0198-8859(91)90011-w · Cited by 10
Cocco, E. E., Mancosu, C., Fadda, E., Murru, M. R., Costa, G., Murru, R., & Marrosu, M. G. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0888-9 · Cited by 5
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Flagged first, then by citations
2 of the 146 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Minden, 1993, Multiple sclerosis: a statistical portrait. A compendium of data on demographics, disability, and health services utilization in the United States
Cited by
Sorted by citations
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
The HLA genomic loci map: expression, interaction, diversity and disease
Shiina, T., Hosomichi, K., Inoko, H., & Kulski, J. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.5 · Cited by 795
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Simpson, S., Blizzard, L., Otahal, P., Van der Mei, I., & Taylor, B. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.240432 · Cited by 718
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
Dankers, W., Colin, E. M., van Hamburg, J. P., & Lubberts, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00697 · Cited by 466
Body size and risk of MS in two cohorts of US women
Munger, K. L., Chitnis, T., & Ascherio, A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0d6e0 · Cited by 441
Metadata
- Authors
- Schmidt, H., Williamson, D., & Ashley-Koch, A.
- Affiliations
- Accelerated Cure Project for Multiple Sclerosis (US)
- Centers for Disease Control and Prevention (US)
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-28
- Volume
- 165
- Issue
- 10
- Pages
- 1097-1109
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2146798707
- Cited by
- 212
- References
- 146
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 10 · 2023: 5 · 2022: 12 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 16 · 2017: 13 · 2016: 9 · 2015: 14 · 2014: 7 · 2013: 15 · 2012: 13
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, HLA-DRB1*1501, HLA-DQA1*0102, HLA-DQB1*0602, genetic susceptibility, HLA complex, allele frequency, case-control study, family-based association study, study design bias
- MeSH terms
- Alleles, Multigene Family, Haplotypes, HLA-D Antigens, Humans, Multiple Sclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review